“Smart cells” is the term that has been adopted by the international scientific community to describe the use of synthetic biology to transform ordinary immune cells into living (“intelligent”) drugs for the treatment of yet incurable diseases, such as cancer, inflammation, and autoimmune disorders.
The scope of the symposium will cover state-of-the-art ways to reprogram immune cells, using innovative signaling circuits, sensory systems, and transduction methodologies. We will also discuss the latest developments in the clinical application of engineered T cells and bench-to-bedside strategies for disseminating research.
Considering the growing interest and remarkable progress in Smart Cells, the LIT would like to invite you and other esteemed colleagues to join us for our Smart Cell Symposium.
The conference will be held on the 29-30th June 2022, in Regensburg, which, as a UNESCO World Heritage site, offers us the perfect setting for 2 days of stimulating and thought-provoking discussions.
To register and for further information, please visit the 2022 LIT Symposium website: